Advertisement

InPharma

, Volume 91, Issue 1, pp 3–3 | Cite as

IS IT TIME FOR A REVISION OF FDA NEW-DRUG REGULATIONS?

Newsletter Article
  • 1 Downloads

Keywords

Marketing Medical Device Supportive Evidence Administrative Cost Drug Regulation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 1977

Personalised recommendations